Treatment of camptocormia with botulinum toxin.
Identifieur interne : 000009 ( PubMed/Corpus ); précédent : 000008; suivant : 000010Treatment of camptocormia with botulinum toxin.
Auteurs : Kelly. Bertram ; Paola Stirpe ; Carlo ColosimoSource :
- Toxicon : official journal of the International Society on Toxinology ; 2015.
Abstract
Camptocormia is defined as an involuntary axial postural distortion of >45° flexion which occurs in the upright position, increases whilst walking and resolves when supine (Ashour and Jankovic, 2006). Unlike orthopaedic or age related kyphosis it is not a fixed structural deformity and produces kyphosis at predominantly lumbar and thoracic rather than cervical regions. Camptocormia has been reported due to a wide range of neurologic, psychiatric, muscular and orthopaedic conditions as well as rare reports of its emergence following the initiation of a number of medications (Finsterer and Strobl, 2010). Parkinson's disease (PD) includes prominent motor features of bradykinesia, rigidity and reduced postural balance responses in all those affected with this disease, but can also cause a range of other motor and non-motor features. Camptocormia is reported in a minority of patients with PD, and it is usually associated with longer disease duration and greater disease burden (Tiple et al., 2009). The aetiology of camptocormia in PD is debated, and responses to treatment have been generally poor and variable between studies. Recent studies have suggested the use of botulinum toxin may improve posture in some affected individuals.
DOI: 10.1016/j.toxicon.2015.06.004
PubMed: 26079953
Links to Exploration step
pubmed:26079953Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of camptocormia with botulinum toxin.</title>
<author><name sortKey="Bertram, Kelly L" sort="Bertram, Kelly L" uniqKey="Bertram K" first="Kelly" last="Bertram">Kelly. Bertram</name>
<affiliation><nlm:affiliation>Neurosciences, Alfred Hospital, Melbourne, Victoria, Australia; Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stirpe, Paola" sort="Stirpe, Paola" uniqKey="Stirpe P" first="Paola" last="Stirpe">Paola Stirpe</name>
<affiliation><nlm:affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation><nlm:affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy. Electronic address: carlo.colosimo@uniroma1.it.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26079953</idno>
<idno type="pmid">26079953</idno>
<idno type="doi">10.1016/j.toxicon.2015.06.004</idno>
<idno type="wicri:Area/PubMed/Corpus">000009</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of camptocormia with botulinum toxin.</title>
<author><name sortKey="Bertram, Kelly L" sort="Bertram, Kelly L" uniqKey="Bertram K" first="Kelly" last="Bertram">Kelly. Bertram</name>
<affiliation><nlm:affiliation>Neurosciences, Alfred Hospital, Melbourne, Victoria, Australia; Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stirpe, Paola" sort="Stirpe, Paola" uniqKey="Stirpe P" first="Paola" last="Stirpe">Paola Stirpe</name>
<affiliation><nlm:affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation><nlm:affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy. Electronic address: carlo.colosimo@uniroma1.it.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Toxicon : official journal of the International Society on Toxinology</title>
<idno type="e-ISSN">1879-3150</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Camptocormia is defined as an involuntary axial postural distortion of >45° flexion which occurs in the upright position, increases whilst walking and resolves when supine (Ashour and Jankovic, 2006). Unlike orthopaedic or age related kyphosis it is not a fixed structural deformity and produces kyphosis at predominantly lumbar and thoracic rather than cervical regions. Camptocormia has been reported due to a wide range of neurologic, psychiatric, muscular and orthopaedic conditions as well as rare reports of its emergence following the initiation of a number of medications (Finsterer and Strobl, 2010). Parkinson's disease (PD) includes prominent motor features of bradykinesia, rigidity and reduced postural balance responses in all those affected with this disease, but can also cause a range of other motor and non-motor features. Camptocormia is reported in a minority of patients with PD, and it is usually associated with longer disease duration and greater disease burden (Tiple et al., 2009). The aetiology of camptocormia in PD is debated, and responses to treatment have been generally poor and variable between studies. Recent studies have suggested the use of botulinum toxin may improve posture in some affected individuals.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="In-Data-Review"><PMID Version="1">26079953</PMID>
<DateCreated><Year>2015</Year>
<Month>11</Month>
<Day>23</Day>
</DateCreated>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3150</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>107</Volume>
<Issue>Pt A</Issue>
<PubDate><Year>2015</Year>
<Month>Dec</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Toxicon : official journal of the International Society on Toxinology</Title>
<ISOAbbreviation>Toxicon</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of camptocormia with botulinum toxin.</ArticleTitle>
<Pagination><MedlinePgn>148-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.toxicon.2015.06.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0041-0101(15)00151-8</ELocationID>
<Abstract><AbstractText>Camptocormia is defined as an involuntary axial postural distortion of >45° flexion which occurs in the upright position, increases whilst walking and resolves when supine (Ashour and Jankovic, 2006). Unlike orthopaedic or age related kyphosis it is not a fixed structural deformity and produces kyphosis at predominantly lumbar and thoracic rather than cervical regions. Camptocormia has been reported due to a wide range of neurologic, psychiatric, muscular and orthopaedic conditions as well as rare reports of its emergence following the initiation of a number of medications (Finsterer and Strobl, 2010). Parkinson's disease (PD) includes prominent motor features of bradykinesia, rigidity and reduced postural balance responses in all those affected with this disease, but can also cause a range of other motor and non-motor features. Camptocormia is reported in a minority of patients with PD, and it is usually associated with longer disease duration and greater disease burden (Tiple et al., 2009). The aetiology of camptocormia in PD is debated, and responses to treatment have been generally poor and variable between studies. Recent studies have suggested the use of botulinum toxin may improve posture in some affected individuals.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bertram</LastName>
<ForeName>Kelly L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo><Affiliation>Neurosciences, Alfred Hospital, Melbourne, Victoria, Australia; Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stirpe</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Colosimo</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy. Electronic address: carlo.colosimo@uniroma1.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>06</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Toxicon</MedlineTA>
<NlmUniqueID>1307333</NlmUniqueID>
<ISSNLinking>0041-0101</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Botulinum toxin</Keyword>
<Keyword MajorTopicYN="N">Camptocormia</Keyword>
<Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>5</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>6</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2015</Year>
<Month>6</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26079953</ArticleId>
<ArticleId IdType="pii">S0041-0101(15)00151-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.toxicon.2015.06.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000009 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000009 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:26079953 |texte= Treatment of camptocormia with botulinum toxin. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26079953" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
This area was generated with Dilib version V0.6.19. |